Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Keratosis

• A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
• A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
• Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
• Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
• Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face
• A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
• Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
• Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients
• The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
• New Treatments for Actinic Keratoses of the Scalp
• A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
• Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization
• A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
• Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
• Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis
• Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With EFUDEX® in the Treatment of Actinic Keratosis
• Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
• Nicotinamide for Prevention of Pre-malignant Actinic Keratosis in Kidney Transplant Recipients
• Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
• Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris
• Pain Management During a Photodynamic Therapy Session on the Vertex for Actinic Keratosis: Tumescent Anesthesia Interest
• Effectiveness of Saline Water and Lidocaine Injections for the Treatment of Intractable Plantar Keratoma
• Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis
• Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis
• Effect of Thymoquinone Extracted From Nigella Sativa in the Treatment of Arsenical Keratosis
• Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
• Effect of Pumpkin Seeds in the Treatment of Moderate to Severe Palmar Arsenical Keratosis
• 5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis
• PDT vs Peels for AKs
• Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
• A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
• Portable Measurement of Protoporphyrin IX in the Skin During Photodynamic Therapy
• Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
• Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
• Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
• Duration of Ameluz Application in Acral Actinic Keratoses Response
• Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
• Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
• Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
• Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream
• Topical Ionic Contra-Viral Therapy in Actinic Keratosis
• Photodynamic Therapy-Induced Immune Modulation: Part III
• Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
• Identification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis
• Effects of Antimicrobials on the Altered Skin Flora in Arsenical Keratosis
• 5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities
• Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis
• Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
• PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
• Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
• An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
• Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients
• Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
• Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis
• Daylight Photodynamic Therapy for Actinic Keratosis
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp
• Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
• Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
• An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis
• A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
• Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion
• Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide
• A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
• A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
• DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients
• Study of SOR007 Ointment for Actinic Keratosis
• Photodynamic Therapy Incubation Times for Actinic Keratosis
• Cryosurgery and Cream Combination for Actinic Keratosis
• Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
• Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
• Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
• Menthol for PDT Pain Relief
• Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis
• Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses
• Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
• Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
• Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
• Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp
• A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
• Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.
• Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy
• A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis
• Daylight-PDT With MAL for AK and Photodamaged Skin
• Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
• Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis
• An Open-Label Safety Study of A-101 Solution
• A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
• A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
• A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
• Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp
• A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel
• Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
• Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
• Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
• Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
• Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
• Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
• A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
• Biological Effects of LEO 43204 in Actinic Keratosis
• The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
• The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice
• Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
• Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
• Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses
• Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
• To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
• A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
• Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
• Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions
• PMS to Evaluate the Safety and Efficacy of Picato® Gel
• Treatment of Actinic Keratoses (AK) on the Face
• Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
• Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients
• To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
• Actinic Keratoses Treatment With Metvix® in Combination With Light
• The Real Life Topical Field Treatment of Actinic Keratosis Study
• Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
• Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis
• Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis
• Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis
• Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively
• Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses
• IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
• Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
• Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis
• Study of A-101 for the Treatment of Seborrheic Keratosis
• Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
• Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis
• Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis
• Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
• Twelve Month Follow-Up of CP0108
• Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
• Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
• Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
• ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
• Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
• A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses
• Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
• Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
• Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
• Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
• Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
• Actinic Keratosis Study
• Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
• Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
• Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)
• A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
• Effects of Topical Diclofenac on Tumor Metabolism
• Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
• A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
• Evaluation of a Topical Treatment for Actinic Keratosis
• Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)
• Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
• Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp
• Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses
• Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
• The Use of Microneedles in Photodynamic Therapy
• Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm
• Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.
• A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
• Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis
• A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
• Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions
• Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis
• Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
• Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
• Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head
• Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp
• Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions
• A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
• Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
• Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease
• Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
• A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
• Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
• Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
• Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
• Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
• Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
• Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)
• PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
• Selenium in the Treatment of Arsenic Toxicity and Cancers
• Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
• 5fluorouracil for Advanced Photoaging
• PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
• LAS41005 in Hyperkeratotic Actinic Keratosis
• Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo
• PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
• Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis
• Fractional CO2 Laser Assisted Photodynamic Therapy
• Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
• Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis
• Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
• Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
• Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis
• A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
• Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
• A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
• A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
• Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
• Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
• A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
• Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
• A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
• A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
• A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
• Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
• ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
• A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
• A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis
• A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
• A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
• Phase II AK Study in Organ Transplant Patients
• Bioequivalence Study of Two Imiquimod Cream 5%
• Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
• The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
• Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
• Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
• A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
• A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
• Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
• Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy
• Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
• Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
• Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
• A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand
• Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
• Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
• Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
• A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
• An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
• Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
• Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
• Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
• Effect of IDEA-070 on Pain and Inflammation Induced by PDT
• Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
• Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
• A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
• A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ
• Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
• The Effect of Efudex Treatment on Photoaged Skin
• Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
• Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
• 1-Year Follow up to the 1473-IMIQ Study
• Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
• Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses
• T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
• Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
• Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
• Green Tea Extract in Treating Patients With Actinic Keratosis
• T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum